Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coppertone (specifically BAY987518 and BAY987517) is a line of topical sunscreen products developed by Bayer. These formulations are designed to provide broad-spectrum protection against ultraviolet A (UVA) and ultraviolet B (UVB) radiation. In clinical trials, these products are evaluated for their Sun Protection Factor (SPF) and UVA protection factor (UVA-PF) to ensure efficacy in preventing sunburn and other UV-induced skin damage. The products are typically applied topically to sun-exposed skin and work by utilizing chemical or physical UV filters that attenuate the amount of radiation reaching the dermal layers. Bayer has conducted multiple clinical trials to validate the SPF efficacy and water-resistance profiles of these specific Coppertone formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Coppertone.